All these products are clinically researched and tested for their potency
But not all fad diets are dangerous, right
When choosing among them, factors such as glycemic efficacy, weight effects and patient preferences may take precedence over concerns about major differences in [GI] risk. She added clinicians should continue to monitor for GI symptoms, particularly early in treatment, as these events, while uncommon, remain more frequent than with some other diabetes drug classes. According to Alkabbani and colleagues, recent trials revealed that dulaglutide (Trulicity, Eli Lilly), semaglutide (Ozempic/Wegovy, Novo Nordisk) and tirzepatide (Zepbound, Eli Lilly) increased the risk for mild to serious GI adverse events like pancreatitis, constipation, nausea, vomiting and biliary disease
People with diagnosed vitamin B12 deficiency or absorption issues should consider discussing injections with their healthcare provider
Diverse macrophage populations mediate acute lung inflammation and resolution
No major drug interaction exists between them
